The realisation of how people could often place their pets’ health above their own occurred to fund manager Fleur Wright with the arrival of two dachshunds into her household during the pandemic.
The addition of Frankie and Salami, combined with a professional instinct to hold stocks that “fly a little bit under the radar”, only served to fuel Wright’s conviction around animal pharmaceutical company Zoetis.
Loading...
Joanne Tran is a markets reporter for The Australian Financial Review in the Sydney newsroom. Connect with Joanne on Twitter. Email Joanne at jo.tran@afr.com